申请人:Beecham Group p.l.c.
公开号:EP0415605A1
公开(公告)日:1991-03-06
A compound of formula (I):
or a tautomeric form thereof and/or a pharmaceutically acceptable salt thereof, and/or a pharmaceutically acceptable solvate thereof, wherein:
A¹ represents a substituted or unsubstituted aryl group;
A² represents a benzene ring having in total up to five substituents;
X represents O, S or NR¹ wherein R¹ represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group, wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group;
Y represents O or S;
R² represents hydrogen;
R³ represents hydrogen or an alkyl, aralkyl or aryl group or R² together with R³ represents a bond; and
n represents an integer in the range of from 2 to 6; a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such compound and composition in medicine.
式(I)化合物
或其同分异构体和/或其药学上可接受的盐和/或其药学上可接受的溶液,其中
A¹ 代表取代或未取代的芳基;
A² 代表总共具有最多五个取代基的苯环;
X代表O、S或NR¹,其中R¹代表氢原子、烷基、酰基、芳烷基,其中芳基可以是取代或未取代的,或取代或未取代的芳基;
Y 代表 O 或 S
R² 代表氢
R³ 代表氢或烷基、芳基或芳基,或 R² 与 R³ 一起代表键;以及
n 代表 2 至 6 范围内的整数;制备这种化合物的工艺、包含这种化合物的药物组合物以及这种化合物和组合物在医药中的用途。